1. Home
  2. Our Firm
  3. News
  4. Schwartz: Harder to Get M&A Deals to the Finish Line

Our Firm

July 25, 2016

Schwartz: Harder to Get M&A Deals to the Finish Line

Guggenheim Partners Chairman Alan Schwartz discusses on CNBC the chilling effect market uncertainty and the fallout from the U.K.’s Brexit vote is having on dealmaking.

 

Important Notices and Disclosures

Guggenheim Securities, LLC, is a New-York-based registered broker dealer and a subsidiary of Guggenheim Partners, LLC. Guggenheim Securities delivers a full range of advisory and financing solutions, sales and trading capabilities, and equity research. The views and strategies described herein may not be suitable for all investors. Past performance does not guarantee future returns. The value of any investment may rise or fall over time. Investing involves risk, including the loss of principal. The content of this video is for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy, or investment product. The material should not be considered research nor is it intended to provide a sufficient basis on which to make an investment decision. Any opinions contained herein are not necessarily those of Guggenheim Partners, LLC or its subsidiaries and are subject to change without notice. Forward looking statements, estimates, and certain information contained herein are based upon proprietary and nonproprietary research and other sources.



July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More

July 12, 2018

Guggenheim Securities Hires Jordan Bliss to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.